America & Europe Eye Drops Market to 2030 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. America & Europe Eye Drops Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. America & Europe Eye Drops Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Rising Prevalence of Ophthalmic Diseases
5.1.2 High Incidence of Age-Related Eye Diseases

5.2 Market Opportunities

5.2.1 Initiatives to Bolster Eye Care Awareness

5.3 Future Trends

5.3.1 Lifestyle Changes Affecting Eye Health

5.4 Impact of Drivers and Restraints

6. America & Europe Eye Drops Market Regional Analysis

6.1 America & Europe Eye Drops Market Overview

6.2 America & Europe Eye Drops Market Revenue 2021-2031 (US$ Billion)

6.3 America & Europe Eye Drops Market Forecast Analysis

7. America & Europe Eye Drops Market Analysis – by Drug Class

7.1 Antibiotics

7.1.1 Overview
7.1.2 Antibiotics: America & Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Billion)

7.2 Artificial Tears

7.2.1 Overview
7.2.2 Artificial Tears: America & Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Billion)

7.3 Steroids

7.3.1 Overview
7.3.2 Steroids: America & Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Billion)

7.4 Others

7.4.1 Overview
7.4.2 Others: America & Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Billion)

8. America & Europe Eye Drops Market Analysis – by Application

8.1 Eye Diseases

8.1.1 Overview
8.1.2 Eye Diseases: America & Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Billion)

8.2 Eye Care

8.2.1 Overview
8.2.2 Eye Care: America & Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Billion)

9. America & Europe Eye Drops Market Analysis – by Purchase Mode

9.1 Prescription and OTC

9.1.1 Overview
9.1.2 Eye Care: America & Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Billion)

10. America & Europe Eye Drops Market – Europe Analysis

10.1 America

10.1.1 America & Europe Eye Drops Market Breakdown, by Key Country, 2024 and 2031 (%)
10.1.1.1 America & Europe Eye Drops Market – Revenue and Forecast Analysis – by Country
10.1.1.1 America : America & Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Billion)

10.1.1.1.1 America : America & Europe Eye Drops Market Breakdown, by Drug Class
10.1.1.1.2 America : America & Europe Eye Drops Market Breakdown, by Application
10.1.1.1.3 America : America & Europe Eye Drops Market Breakdown, by Purchase Mode

10.2 Europe

10.2.1 America & Europe Eye Drops Market Breakdown, by Key Country, 2024 and 2031 (%)
10.2.1.1 America & Europe Eye Drops Market – Revenue and Forecast Analysis – by Country
10.2.1.1 UK: America & Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Billion)

10.2.1.1.1 UK: America & Europe Eye Drops Market Breakdown, by Drug Class
10.2.1.1.2 UK: America & Europe Eye Drops Market Breakdown, by Application
10.2.1.1.3 UK: America & Europe Eye Drops Market Breakdown, by Purchase Mode

10.2.1.2 Germany: America & Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Billion)

10.2.1.2.1 Germany: America & Europe Eye Drops Market Breakdown, by Drug Class
10.2.1.2.2 Germany: America & Europe Eye Drops Market Breakdown, by Application
10.2.1.2.3 Germany: America & Europe Eye Drops Market Breakdown, by Purchase Mode

10.2.1.3 France: America & Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Billion)

10.2.1.3.1 France: America & Europe Eye Drops Market Breakdown, by Drug Class
10.2.1.3.2 France: America & Europe Eye Drops Market Breakdown, by Application
10.2.1.3.3 France: America & Europe Eye Drops Market Breakdown, by Purchase Mode

10.2.1.4 Russia: America & Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Billion)

10.2.1.4.1 Russia: America & Europe Eye Drops Market Breakdown, by Drug Class
10.2.1.4.2 Russia: America & Europe Eye Drops Market Breakdown, by Application
10.2.1.4.3 Russia: America & Europe Eye Drops Market Breakdown, by Purchase Mode

10.2.1.5 Italy: America & Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Billion)

10.2.1.5.1 Italy: America & Europe Eye Drops Market Breakdown, by Drug Class
10.2.1.5.2 Italy: America & Europe Eye Drops Market Breakdown, by Application
10.2.1.5.3 Italy: America & Europe Eye Drops Market Breakdown, by Purchase Mode

10.2.1.6 Rest of Europe : America & Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Billion)

10.2.1.6.1 Rest of Europe : America & Europe Eye Drops Market Breakdown, by Drug Class
10.2.1.6.2 Rest of Europe : America & Europe Eye Drops Market Breakdown, by Application
10.2.1.6.3 Rest of Europe : America & Europe Eye Drops Market Breakdown, by Purchase Mode

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. America & Europe Eye Drops Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Alcon AG

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 AbbVie Inc

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Bausch & Lomb Inc

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Pfizer Inc

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Prestige Consumer Healthcare Inc.

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Similasan Corp

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Rohto Pharmaceutical Co Ltd

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Sager Pharma Kft

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Akorn Operating Company LLC

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Santen Pharmaceutical Co., Ltd.

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

13.11 SERVImed Industrial S.p.A.

13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments

13.12 I-MED Pharma Inc.

13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.12.6 Key Developments

13.13 urope Eye Drops Market

13.13.1 Key Facts
13.13.2 Business Description
13.13.3 Products and Services
13.13.4 Financial Overview
13.13.5 SWOT Analysis
13.13.6 Key Developments

14. Appendix

14.1 About Business Market Insights